Effects of Foot Center of Pressure Manipulation on Hip Osteoarthritis Patients During Gait

July 6, 2015 updated by: HaEmek Medical Center, Israel

Effects of Foot Center of Pressure Manipulation on Hip Biomechanics, Muscle Activation Patterns, and Energy Consumption During Gait in Hip Osteoarthritis Patients

The purpose of this study is to:

  1. Analyze the short-term effects of external center of pressure manipulation of the foot in idiopathic hip osteoarthritis patients during gait on:

    1. Gait parameters (spatiotemporal, kinematic, and kinetic)
    2. Muscle activation patterns of the lower limbs and back
  2. Analyze the long-term effects (during the period of one year) of external center of pressure manipulation of the foot in idiopathic hip osteoarthritis patients during gait on:

    1. Gait parameters (spatiotemporal, kinematic, and kinetic)
    2. Motor learning and muscle activation patterns
    3. Energy consumption
    4. Pain, physical function, and quality of life

The hypotheses of the study, in reference to the aforementioned study objectives are:

  1. Changes in foot center of pressure will have an immediate effect on gait parameters and muscle activation patterns of the lower limbs and back.
  2. Long-term manipulation of foot center of pressure, as a result of a year-long rehabilitation program using the AposTherapy Biomechanical System, will result in improvement in gait parameters, changes in muscle activation patterns as a result of new motor learning, improvement in energy consumption, decrease in pain, improvement in physical function, and improvement in quality of life.

Study Overview

Status

Completed

Conditions

Detailed Description

This study is a randomized prospective controlled study assessing the short and long-term effects of external foot center-of-pressure manipulation on gait pattern, muscle activation pattern, energy consumption, physical function, pain, and quality of life. Sixty patients will be recruited for the study and divided randomly into two groups, an experimental group (thirty patients) and a control group (thirty patients). Both groups will be similar with respect to demographic and pathological profiles.

The experimental group will be fitted with a customized biomechanical device worn on the feet (AposTherapy Biomechanical System, AposTherapy - Sports and Medical Technologies Ltd., Hertzlia, Israel). The device is custom calibrated for each patient. The device allows center of pressure manipulation for all phases of the gait cycle and induces controlled perturbation during gait. The immediate effects of the device will be evaluated using center of pressure measurements, three-dimensional gait analysis, and surface electromyography. Following this, patients will be instructed to walk with the device at home on a daily basis according to a customized AposTherapy therapy protocol. They will return to the laboratory for measurements of gait pattern, muscle activation pattern, energy consumption, physical function, pain, and quality of life after three months, six months, and twelve months from the start of the therapy protocol. Data from the analyses will be used to reveal potential changes in the aforementioned measurements as a result of the study intervention.

The control group will carry out the same measurements in the laboratory over the period of one year, however without the biomechanical intervention device.

Study Type

Interventional

Enrollment (Actual)

14

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Haifa, Israel
        • Biorobotics and Biomechanics Lab, Technion Israel Institute of Technology

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

50 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Women age 50 and over with unilateral or bilateral idiopathic hip osteoarthritis

Exclusion Criteria:

  • Previous surgery on the lower limbs or back
  • Previous musculoskeletal injuries and/or diseases of the lower limbs or back
  • Cognitive disabilities and/or inability to cooperate or understand study instructions
  • Vestibular problems and/or use of a walking aid
  • Neurological and/or orthopaedic and/or cardiovascular and/or pulmonary disorders or risks that may impact the patient's functional performance or limit exercise

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental
These patients will carry out a therapy program with the study intervention device.
The system is a rehabilitation program implementing a device comprised of four adjustable modular elements attached to foot-worn platforms that are capable of manipulating the foot's center of pressure and applying perturbation training throughout the gait cycle. The device allows for neuromuscular training during dynamic loading.
Active Comparator: Control
The patients in this group will not carry out a therapy program with the study intervention device.
No intervention will be prescribed to the control group during participation in the study.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from Baseline in Gait Patterns at 3 months, 6 months, and 12 months
Time Frame: From beginning of patient participation in study, after 3 months, after 6 months, and after 12 months

Three-dimensional gait analysis of spatiotemporal, kinetic, and kinematic parameters.

Center of pressure measurements.

From beginning of patient participation in study, after 3 months, after 6 months, and after 12 months
Change from Baseline in Muscle Activation Patterns at 3 months, 6 months, and 12 months
Time Frame: From beginning of patient participation in study, after 3 months, after 6 months, and after 12 months
Surface electromyographic analysis of muscle activation patterns.
From beginning of patient participation in study, after 3 months, after 6 months, and after 12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from Baseline in Physical Function at 3 months, 6 months, and 12 months
Time Frame: From beginning of patient participation in study, after 3 months, after 6 months, and after 12 months

Self-evaluation questionnaires.

Physical function tests.

Energy consumption measurements.

From beginning of patient participation in study, after 3 months, after 6 months, and after 12 months
Change from Baseline in Pain at 3 months, 6 months, and 12 months
Time Frame: From beginning of patient participation in study, after 3 months, after 6 months, and after 12 months
Self-evaluation questionnaires.
From beginning of patient participation in study, after 3 months, after 6 months, and after 12 months
Change from Baseline in Quality of Life Assessments at 3 months, 6 months, and 12 months
Time Frame: From beginning of patient participation in study, after 3 months, after 6 months, and after 12 months
Self-evaluation questionnaires.
From beginning of patient participation in study, after 3 months, after 6 months, and after 12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2012

Primary Completion (Actual)

December 1, 2014

Study Completion (Actual)

December 1, 2014

Study Registration Dates

First Submitted

October 3, 2011

First Submitted That Met QC Criteria

October 10, 2011

First Posted (Estimate)

October 12, 2011

Study Record Updates

Last Update Posted (Estimate)

July 7, 2015

Last Update Submitted That Met QC Criteria

July 6, 2015

Last Verified

July 1, 2015

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hip Osteoarthritis

Clinical Trials on AposTherapy Biomechanical System

3
Subscribe